BUCCI, Marco
 Distribuzione geografica
Continente #
EU - Europa 4.432
NA - Nord America 3.812
AS - Asia 2.073
SA - Sud America 85
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 10.430
Nazione #
US - Stati Uniti d'America 3.783
IT - Italia 1.263
SG - Singapore 857
CN - Cina 658
IE - Irlanda 580
UA - Ucraina 480
SE - Svezia 478
DE - Germania 460
FR - Francia 426
TR - Turchia 329
GB - Regno Unito 308
FI - Finlandia 189
IN - India 143
RU - Federazione Russa 91
BR - Brasile 79
HK - Hong Kong 30
BE - Belgio 25
NL - Olanda 22
CA - Canada 21
PL - Polonia 21
AT - Austria 13
CH - Svizzera 10
ES - Italia 10
IR - Iran 10
CZ - Repubblica Ceca 9
EG - Egitto 9
GR - Grecia 9
EU - Europa 8
IL - Israele 8
LT - Lituania 7
MX - Messico 7
VN - Vietnam 6
ID - Indonesia 5
MY - Malesia 5
SI - Slovenia 5
BD - Bangladesh 4
EE - Estonia 4
JP - Giappone 4
AL - Albania 3
AU - Australia 3
EC - Ecuador 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
DK - Danimarca 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
PK - Pakistan 2
RO - Romania 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
MC - Monaco 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 10.430
Città #
Chandler 720
Singapore 566
Jacksonville 565
Dublin 561
Princeton 254
Munich 242
Southend 222
Izmir 197
The Dalles 162
Nanjing 157
Ashburn 144
Beijing 132
Ann Arbor 119
Wilmington 110
Pescara 107
Helsinki 102
Dearborn 97
Santa Clara 97
Cambridge 92
Chieti 91
New York 89
Milan 72
Boardman 69
Nanchang 63
Altamura 62
Los Angeles 62
Rome 45
Woodbridge 40
Shenyang 35
Hebei 31
Foggia 30
Tianjin 30
Washington 28
Houston 27
Brussels 24
Nuremberg 22
Hong Kong 21
Jinan 21
Kunming 19
Norwalk 17
Bologna 15
Zhengzhou 15
Florence 14
Grevenbroich 14
Hangzhou 14
Ningbo 13
Auburn Hills 12
Changsha 12
Jiaxing 12
Guangzhou 11
London 11
Orange 11
Toronto 11
Brooklyn 10
Kraków 10
San Mateo 10
Taizhou 10
Frankfurt am Main 9
Moscow 9
Seattle 9
Bari 8
Brno 8
Lanzhou 8
Mountain View 8
Palermo 8
Amsterdam 7
Avellino 7
Catania 7
Changchun 7
Padova 7
San Francisco 7
Spoltore 7
São Paulo 7
Andover 6
Augusta 6
Brescia 6
Campobasso 6
Catanzaro 6
Falls Church 6
Naples 6
Nocera Inferiore 6
Simi Valley 6
Chicago 5
Dong Ket 5
Grugliasco 5
Hefei 5
Jyväskylä 5
Legnano 5
Napoli 5
Rio de Janeiro 5
Sala Baganza 5
San Vito Chietino 5
Shanghai 5
Stockholm 5
Turin 5
Warsaw 5
Athens 4
Carini 4
Council Bluffs 4
Florianópolis 4
Totale 6.012
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 488
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 210
MicroRNA profiling in migraine without aura: Pilot study 186
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 181
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 139
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 132
Uneven accuracy of home blood pressure measurement: a multi-centric survey 128
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 126
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 117
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 117
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 114
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 114
A unique microRNA signature associated with plaque instability in humans. 111
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 110
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 110
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 109
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 108
A unique microRNA signature associated with ischemic stroke in humans 107
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 107
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 105
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 102
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 101
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 99
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 99
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 98
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 98
Association between 5-lipoxygenase expression and plaque instability in humans. 97
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 96
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 95
Ipertensione arteriosa ed algosensibilità muscolare 93
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 93
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 93
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 92
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 92
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 91
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 91
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 90
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 90
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 90
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 89
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 89
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 88
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 88
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 87
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 87
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 86
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 85
The (K+)ey of the problem 85
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 84
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 84
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 84
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 83
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 83
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 83
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 83
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 82
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 81
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 81
Possible indication of coronary risk trough discriminant functions. 80
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 80
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 80
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 80
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 79
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 79
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 78
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 77
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 77
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 77
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 77
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 77
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 76
COVID-19 and RAS: Unravelling an Unclear Relationship 75
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 73
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 73
Hypertension modulates miR-145 expression in human atherosclerotic plaques 73
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 73
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 72
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 72
Impact of hypertension on somatic pain sensitivity in chronic headache 72
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 71
Muscle pain sensitivity in hypertensive patients with and without chronic pain 71
null 71
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 71
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 70
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 69
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 69
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 69
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 68
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 68
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 68
Effects of Rosuvastatin on the expression of microRNAs and their putative targets in human atherosclerotic plaques: the QUASAR Study 66
Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation 65
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 63
null 63
Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry. 62
LA MALATTIA DI BARLOW NELLO SPORTIVO: TECNICA CHIRURGICA INNOVATIVA 62
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 62
The fascinating relationship between liver stiffness and cholesterol 62
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 61
Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study 61
Totale 9.323
Categoria #
all - tutte 44.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020231 0 0 0 0 0 0 0 0 0 0 170 61
2020/2021829 116 15 118 36 64 149 35 38 82 90 36 50
2021/2022744 34 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20252.375 133 449 356 74 103 144 217 159 356 145 239 0
Totale 10.918